• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 II 期和 III 期结直肠癌中进行强化影像学和生物标志物监测。

Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer.

机构信息

Department of Medicine, Roswell Park Cancer Institute, Buffalo, N.Y., USA.

出版信息

Oncology. 2012;82(1):41-7. doi: 10.1159/000333855. Epub 2012 Jan 26.

DOI:10.1159/000333855
PMID:22286543
Abstract

OBJECTIVE

The objective of this study was to determine the rate of salvage resections in patients with stage II and III colorectal cancer following intensive surveillance in a comprehensive cancer center.

METHODS

Patients with stage II and III colorectal cancer with a minimum follow-up of 3 years were included. Carcinoembryonic antigen was obtained every 3 months for 2 years and then every 6 months for years 3-5. CT scans of the chest, abdomen and pelvis were performed every 6 months for 2 years and then yearly for years 3-5. Colonoscopy was performed at year 1 and then every 3 years.

RESULTS

One hundred and seventy-seven patients were followed for a median of 60 months; 44 patients were diagnosed with recurrent disease. CT was the first sign of recurrence in 68% of patients. Carcinoembryonic antigen test was normal in 20 patients (45%) at the time of disease recurrence. Twenty-five patients (57%) with recurrent disease underwent curative-intent resection, 12 of whom are still cancer free at a median follow-up of 81 months.

CONCLUSIONS

In this retrospective study, intensive radiographic screening was associated with a high salvage resection rate, which led to favorable clinical outcomes. Randomized clinical trials are urgently needed to define the optimal duration and schedule of radiographic screening in stage II and III colorectal cancer.

摘要

目的

本研究旨在确定在综合癌症中心进行强化监测后,II 期和 III 期结直肠癌患者进行挽救性切除术的比率。

方法

纳入至少随访 3 年的 II 期和 III 期结直肠癌患者。在最初的 2 年内,每 3 个月检测一次癌胚抗原,然后在第 3 至 5 年期间每 6 个月检测一次。在最初的 2 年内,每 6 个月进行一次胸部、腹部和骨盆的 CT 扫描,然后在第 3 至 5 年期间每年进行一次。在第 1 年进行结肠镜检查,然后每 3 年进行一次。

结果

177 例患者的中位随访时间为 60 个月;44 例患者被诊断为疾病复发。在 68%的患者中,CT 是复发的第一个迹象。在疾病复发时,20 例患者(45%)癌胚抗原检测正常。25 例(57%)复发患者接受了根治性切除术,其中 12 例在中位随访 81 个月时仍无癌症。

结论

在这项回顾性研究中,强化影像学筛查与高挽救性切除术率相关,这导致了良好的临床结果。迫切需要进行随机临床试验来确定 II 期和 III 期结直肠癌影像学筛查的最佳持续时间和方案。

相似文献

1
Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer.在 II 期和 III 期结直肠癌中进行强化影像学和生物标志物监测。
Oncology. 2012;82(1):41-7. doi: 10.1159/000333855. Epub 2012 Jan 26.
2
Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.专门的癌症中心监测计划对 II 期和 III 期结直肠癌患者遵循指南情况的影响。
Clin Colorectal Cancer. 2013 Jun;12(2):103-12. doi: 10.1016/j.clcc.2012.09.006. Epub 2012 Nov 13.
3
Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.接受根治性切除的结直肠癌患者的术后监测:一项前瞻性、多中心、随机对照试验。
J Clin Oncol. 2006 Jan 20;24(3):386-93. doi: 10.1200/JCO.2005.02.0826. Epub 2005 Dec 19.
4
Is early surveillance with CT scan necessary in patients with stage II/III colorectal cancer: a retrospective study.是否有必要对 II/III 期结直肠癌患者进行早期 CT 扫描监测:一项回顾性研究。
J Surg Oncol. 2013 Dec;108(8):568-71. doi: 10.1002/jso.23432. Epub 2013 Sep 16.
5
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.3 至 5 年定期 CEA 和 CT 随访检测结直肠癌复发的效果:FACS 随机临床试验。
JAMA. 2014 Jan 15;311(3):263-70. doi: 10.1001/jama.2013.285718.
6
Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.更频繁与不那么频繁的随访检测对 II 期或 III 期结直肠癌患者总死亡率和结直肠癌特异性死亡率的影响:COLOFOL 随机临床试验。
JAMA. 2018 May 22;319(20):2095-2103. doi: 10.1001/jama.2018.5623.
7
Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.评估结直肠癌和癌胚抗原水平升高患者的肿瘤复发:FDG PET/CT 与对比增强 64 层 MDCT 胸部和腹部检查。
AJR Am J Roentgenol. 2010 Mar;194(3):766-71. doi: 10.2214/AJR.09.3205.
8
Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.结直肠癌根治性切除术后肺转移高危患者的识别。
J Med Assoc Thai. 2012 May;95 Suppl 5:S86-91.
9
CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.癌胚抗原(CEA)、组织多肽特异性抗原(TPS)、糖类抗原19-9(CA 19-9)、糖类抗原72-4(CA 72-4)及粪便潜血试验在结直肠癌手术切除术前诊断及随访中的应用
Anticancer Res. 1999 Jul-Aug;19(4A):2443-50.
10
Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.退伍军人健康管理局医疗机构中结直肠癌幸存者的计算机断层扫描监测模式。
Cancer. 2017 Jun 15;123(12):2338-2351. doi: 10.1002/cncr.30569. Epub 2017 Feb 17.

引用本文的文献

1
Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.评估结直肠癌患者术后循环肿瘤 DNA、影像学和癌胚抗原水平的比较监测策略。
JAMA Netw Open. 2022 Mar 1;5(3):e221093. doi: 10.1001/jamanetworkopen.2022.1093.
2
Combination of C-reactive Protein and Monocyte Count Is a Useful Prognostic Indicator for Patients With Colorectal Cancer.C 反应蛋白与单核细胞计数联合是结直肠癌患者有用的预后指标。
In Vivo. 2020 Jan-Feb;34(1):299-305. doi: 10.21873/invivo.11774.
3
Prognostic Value of Combined Tumor Marker and Controlling Nutritional Status (CONUT) Score in Colorectal Cancer Patients.
联合肿瘤标志物与控制营养状况(CONUT)评分在结直肠癌患者中的预后价值
Yonago Acta Med. 2019 Mar 28;62(1):124-130. doi: 10.33160/yam.2019.03.017. eCollection 2019 Mar.
4
Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients.术前和术后C反应蛋白联合检测在结直肠癌患者中的预后价值
Surg Today. 2018 Nov;48(11):986-993. doi: 10.1007/s00595-018-1689-9. Epub 2018 Jun 26.
5
Elevated Serum Carcinoembryonic Antigen Is Associated with a Worse Survival Outcome of Patients After Liver Resection for Hepatocellular Carcinoma: a Propensity Score Matching Analysis.血清癌胚抗原升高与肝细胞癌肝切除术后患者较差的生存结局相关:一项倾向评分匹配分析
J Gastrointest Surg. 2016 Dec;20(12):2063-2073. doi: 10.1007/s11605-016-3295-8. Epub 2016 Oct 11.
6
Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.结直肠癌根治性切除术后强化随访的替代方案。潜在的新的推荐生物标志物。
Pathol Oncol Res. 2013 Oct;19(4):619-29. doi: 10.1007/s12253-013-9672-7. Epub 2013 Jul 19.
7
How often should we perform surveillance colonoscopy after surgery for colorectal cancer?结直肠癌手术后我们应该多久进行一次结肠镜监测?
Int J Colorectal Dis. 2013 Jun;28(6):835-40. doi: 10.1007/s00384-012-1613-5. Epub 2012 Nov 21.